KRYS NASDAQ
Krystal Biotech, Inc.
1W: -6.8%
1M: -12.7%
3M: -14.0%
YTD: +30.5%
1Y: +79.4%
3Y: +178.6%
5Y: +472.5%
$322.28
-3.03 (-0.93%)
Weekly Expected Move ±4.0%
$296
$309
$322
$335
$348
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-07-07
Earliest Filing
2021-07-07
Latest Filing
supplier: 1
Counterparties (Filed by KRYS)
1 relationshipsCompanies named in KRYS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| The Whiting-Turner Contracting Company | — | supplier | Construction and management of Krystal's second commercial gene therapy facility | 2021-07-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-03 | Earnings Release; Exhibits | View | |
| 2026-07-21 | Other Events; Exhibits | View | |
| 2026-05-20 | Shareholder Vote | View | |
| 2026-05-04 | Exhibits | View | |
| 2026-02-17 | Results of Operations and Financial Condition | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-03 | Results of Operations and Financial Condition | View | |
| 2025-10-22 | Other Events | View | |
| 2025-08-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-25 | Regulation FD Disclosure | View | |
| 2025-07-24 | Regulation FD Disclosure | View | |
| 2025-07-09 | Regulation FD Disclosure | View | |
| 2025-06-02 | Other Events | View | |
| 2025-05-19 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Regulation FD Disclosure | View | |
| 2025-05-06 | Regulation FD Disclosure | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-28 | Regulation FD Disclosure | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR